Horizon steps up its official Depomed pursuit with campaign website

Horizon Pharma ($HZNP) has officially begun mailing solicitation materials to shareholders of unwilling M&A target Depomed ($DEPO), including a letter related to its efforts to call the two special meetings it'll need if it wants to seal its deal. And should Depomed's investors need more information, Horizon has set up a website--www.HorizonAndDepomed.com--complete with details, stats and more. Release

Suggested Articles

Turns out Procter & Gamble didn’t want Pfizer’s consumer health unit after all. But it did want Merck KGaA’s.

Private equity firm, in exclusive talks with Sanofi, says it'll invest to pump up Zentiva into an "independent European generics leader."

With suitor Takeda circling Shire, the Dublin-based target has pulled off a deal of its own.